Maryland denies accused over-stenter’s bid to reclaim medical license
Maryland Judge Susan Souder denied a medical license reinstatement bid by Dr. Mark Midei, who is accused of implanting stents in hundreds of patients who didn’t need them, after the state’s medical board decided that the doctor committed "repeated and serious" violations.
"I remain certain of the soundness of my medical decisions throughout my 25-year career as an interventional cardiologist in Baltimore," Midei told TheHeart.org. "I am also certain that my practice did not differ from that of my colleagues at St. Joseph, in Baltimore, or across the United States."
Midei last month lost a bid to charge his former employer, St. Joseph Medical Center, with defamation. He has previously stated that St. Joseph attempted to foist the blame of the unnecessary stents on him, raising questions over whether the institution itself was guilty of fraudulent medical practice.
Midei, who is accused of implanting unnecessary stents in as many as 369 patients, has claimed innocence. . The case is under review by the U.S. Dept. of Health & Human Services.
Read more
Read more medical device legal news from MassDevice.com
Coloplast claims victory against Generic Medical Devices in patent spat
Coloplast (CPH:COLO B) touted a legal victory in defending its intellectual property against Generic Medical Devices Inc., which Coloplast accused of patent infringement for the transobturator method for treating stress urinary incontinence in women. The transobturator methods involves surgically implanting a sling to help control the bladder.
A jury decided in Coloplast’s favor that GMD infringed 6 patent claims, and the court is set to deliberate on a possible permanent injunction to prevent GMD from selling its surgical tools and sling products. Read more
Cordis pursues subpoenas in stent lawsuit against Abbott
Johnson & Johnson (NYSE:JNJ) subsidiary Cordis Corp. pursued its claim that a the U.S. Patent & Trademark Office wrongly denied the company the ability to submit key subpoenas that prevented it from defending its patents in a stent lawsuit against Boston Scientific (NYSE:BSX) and Abbott (NYSE:ABT).
Cordis sued the USPTO in January claiming that the agency "hindered Cordis’ ability to obtain and present evidence that is relevant to disputed factual issues," adding that the USPTO’s decisions "have caused, and threaten to cause, injury to Cordis’ business or property for which Cordis has no adequate remedy at law." Read more
